A clinical trial to study the effect of the drug Kandhaga Rasayanam in patients having Azhal Neerchurukku (Urinary Tract Infection)

Phase II Non-Randomized Open Clinical Evaluation of siddha medicine Kandhaga Rasayanam for the management of Azhal Neer churukku (Urinary Tract Infection)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037773

Enrollment

Registered

2021-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Kandhaga Rasayanam: 1to2 gm, twice a day for 15 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Subjrcts within 20-60 years, having symptoms such as, Frequency of Urination, Burning micturition, Dysuria, Lower abdominal pain, Low bach ache, Hematuria, patients with significant for bacteria in urine culture, patients having moderate to severe symptoms according to UTI symptom assessment scale

Exclusion criteria

Exclusion criteria: Pregnant women, History of Diabetes mellitus, History of sexually transmitted disease, History of Malignancy will be excluded

Design outcomes

Primary

Measure	Time frame
It is mainly assessed by reduction in clinical signs and symptoms by UTI symptom assessment score and also assessed by urine culture when bacterial/fungal infection becomes negative after treatmentTimepoint: 15 days	—

Secondary

Measure	Time frame
By comparing the clinical signs and symptoms and the urine culture before and after the treatmentTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Menaka R

Government Siddha Medical College

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026